Quest Diagnostics Inc Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge
Quest Diagnostics Inc (DGX) had Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge of $65.20 million as of 2012-09-30, per its 10-Q filed 2012-10-24.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments
us-gaap:DeferredGainLossOnDiscontinuationOfInterestRateFairValueHedge · last filed 2013-04-24
- 2012-09-30: Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge $65.20M.
- 2012-07-31: Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge $65.20M.
| Period end | Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge |
|---|---|
| 2012-09-30 | $65.20M 10-Q · filed 2012-10-24 |
| 2012-07-31 | $65.20M 10-Q · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |